RN7SL558P

Across TCGA pan-cancer cohorts, RN7SL558P RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of RN7SL558P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL558P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL558P is over-expressed in tumor.

HNSC, LIHC, and BLCA are the cancer types where RN7SL558P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL558P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.216	<.001	8	view →
LIHC	Male	All	+0.135	.009	5	view →
BLCA	All	All	+0.266	.038	3	view →
COAD	All	All	+0.218	.010	3	view →
LUSC	Female	II,III,IV	+0.647	.003	2	view →
UCEC	All	II,III,IV	+0.319	.039	2	view →
KICH	Female	III,IV	+0.306	.011	2	view →
STAD	All	All	+0.412	.032	1	view →
READ	All	All	+0.346	.044	1	view →
LUAD	All	All	+0.334	.047	1	view →
KIRC	All	All	+0.109	.011	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

RN7SL558P–HNSC

Open the HNSC breakdown →